HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Alzheimer Disease D000544 76 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Bacterial Infections D001424 21 associated lipids
Blister D001768 16 associated lipids
Body Weight D001835 333 associated lipids
Bone Diseases D001847 4 associated lipids
Brain Diseases D001927 27 associated lipids
Brain Neoplasms D001932 15 associated lipids
Breast Neoplasms D001943 24 associated lipids
Calcinosis D002114 5 associated lipids
Candidiasis D002177 3 associated lipids
Carcinoma D002277 18 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Carcinosarcoma D002296 7 associated lipids
Cerebellar Neoplasms D002528 9 associated lipids
Intracranial Embolism and Thrombosis D002542 5 associated lipids
Brain Ischemia D002545 89 associated lipids
Uterine Cervical Neoplasms D002583 10 associated lipids
Choroid Neoplasms D002830 2 associated lipids
Coccidioidomycosis D003047 2 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Colorectal Neoplasms, Hereditary Nonpolyposis D003123 2 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Coronary Disease D003327 70 associated lipids
Congenital Hypothyroidism D003409 1 associated lipids
Dental Pulp Necrosis D003790 6 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diarrhea D003967 32 associated lipids
Dientamoebiasis D004030 1 associated lipids
Dysentery, Amebic D004404 3 associated lipids
Echinococcosis D004443 2 associated lipids
Embolism D004617 3 associated lipids
Equine Infectious Anemia D004859 1 associated lipids
Femoral Neck Fractures D005265 3 associated lipids
Fetomaternal Transfusion D005331 1 associated lipids
Glomerulonephritis D005921 35 associated lipids
Glucagonoma D005935 2 associated lipids
Granuloma D006099 5 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Heart Arrest D006323 13 associated lipids
Heart Diseases D006331 8 associated lipids
Hirschsprung Disease D006627 3 associated lipids
Hyperplasia D006965 34 associated lipids
Hypothyroidism D007037 32 associated lipids
Creutzfeldt-Jakob Syndrome D007562 7 associated lipids
Keratosis D007642 9 associated lipids
Laryngeal Neoplasms D007822 7 associated lipids
Lip Neoplasms D008048 3 associated lipids
Listeriosis D008088 12 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphoproliferative Disorders D008232 7 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Medulloblastoma D008527 22 associated lipids
Meningioma D008579 11 associated lipids
Mesonephroma D008649 1 associated lipids
Metaplasia D008679 7 associated lipids
Adenoma, Pleomorphic D008949 1 associated lipids
Mouth Diseases D009059 5 associated lipids
Mycoses D009181 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Neoplasms, Multiple Primary D009378 8 associated lipids
Neurilemmoma D009442 10 associated lipids
Occupational Diseases D009784 42 associated lipids
Palatal Neoplasms D010157 2 associated lipids
Paraganglioma, Extra-Adrenal D010236 1 associated lipids
Parotid Neoplasms D010307 2 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Poultry Diseases D011201 21 associated lipids
Precancerous Conditions D011230 48 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Rabies D011818 4 associated lipids
Respiratory Sounds D012135 3 associated lipids
Rhabdomyoma D012207 1 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Rodent Diseases D012376 4 associated lipids
Sarcoma D012509 3 associated lipids
Osteosarcoma D012516 50 associated lipids
Schistosomiasis haematobia D012553 1 associated lipids
Sertoli Cell Tumor D012707 1 associated lipids
Sigmoid Neoplasms D012811 5 associated lipids
Sinusitis D012852 9 associated lipids
Skin Neoplasms D012878 12 associated lipids
Spinal Cord Neoplasms D013120 3 associated lipids
Stomach Neoplasms D013274 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Swine Diseases D013553 16 associated lipids
Teratoma D013724 4 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Costa-Nogueira C et al. Synthesis and expression of CDw75 antigen in human colorectal cancer. 2009 BMC Cancer pmid:20003255
Fritzsche FR et al. ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. 2008 BMC Cancer pmid:18582378
Zhang B et al. Expression of RECK and matrix metalloproteinase-2 in ameloblastoma. 2009 BMC Cancer pmid:19995435
Wang Q et al. Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis. 2011 BMC Cancer pmid:21702992
Gambichler T et al. Pattern of mRNA expression of beta-defensins in basal cell carcinoma. 2006 BMC Cancer pmid:16796735
Chaube A et al. Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582. 2006 BMC Cancer pmid:16686942
Hamtiaux L et al. The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action. 2012 BMC Cancer pmid:22429826
Kalinina T et al. Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung. 2010 BMC Cancer pmid:20553613
Kalliomäki TM et al. Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model. 2008 BMC Cancer pmid:18507854
Zhang D et al. Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study. 2010 BMC Cancer pmid:21108842
Nykopp TK et al. Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content. 2009 BMC Cancer pmid:19435493
Muinelo-Romay L et al. Identification of α(1,6)fucosylated proteins differentially expressed in human colorectal cancer. 2011 BMC Cancer pmid:22152070
Tong QS et al. BAK overexpression mediates p53-independent apoptosis inducing effects on human gastric cancer cells. 2004 BMC Cancer pmid:15248898
Morrone FB et al. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. 2006 BMC Cancer pmid:16995949
Chanrion M et al. A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study. 2007 BMC Cancer pmid:17338809
Nordfors K et al. The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis. 2010 BMC Cancer pmid:20398423
Wu Z et al. Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma. 2009 BMC Cancer pmid:19732464
Lüchtenborg M et al. Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study. 2005 BMC Cancer pmid:16356174
Hadad SM et al. Histological evaluation of AMPK signalling in primary breast cancer. 2009 BMC Cancer pmid:19723334
Machado CM et al. Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro. 2008 BMC Cancer pmid:18840301
Sun S et al. A protein-based set of reference markers for liver tissues and hepatocellular carcinoma. 2009 BMC Cancer pmid:19725976
Deschoolmeester V et al. Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer. 2010 BMC Cancer pmid:20346145
Szybka M et al. cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer. 2009 BMC Cancer pmid:19671129
Kempkensteffen C et al. Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer. 2009 BMC Cancer pmid:19664236
Hung MS et al. Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library. 2009 BMC Cancer pmid:19419583
Lööf J et al. Impact of PINCH expression on survival in colorectal cancer patients. 2011 BMC Cancer pmid:21426571
Van der Auwera I et al. Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients. 2010 BMC Cancer pmid:20226036
Nyalendo C et al. Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression. 2009 BMC Cancer pmid:19961596
Tomlinson VA et al. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. 2005 BMC Cancer pmid:16156888
Cheng Y et al. Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection. 2007 BMC Cancer pmid:17927838
Ihnen M et al. Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients. 2012 BMC Cancer pmid:22475274
Papageorgiou KI and Kaniorou-Larai MG A case report of Merkel cell carcinoma on chronic lymphocytic leukemia: differential diagnosis of coexisting lymphadenopathy and indications for early aggressive treatment. 2005 BMC Cancer pmid:16111484
Bedin V et al. Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma. 2010 BMC Cancer pmid:20525386
Graziano F et al. Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer. 2001 BMC Cancer pmid:11518545
Jörissen H et al. Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer. 2009 BMC Cancer pmid:19552806
Lo Muzio L et al. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study. 2005 BMC Cancer pmid:15967043
Genelhu MC et al. A comparative study between mixed-type tumours from human salivary and canine mammary glands. 2007 BMC Cancer pmid:18045453
Fu J et al. In vitro anti-angiogenic properties of LGD1069, a selective retinoid X-receptor agonist through down-regulating Runx2 expression on Human endothelial cells. 2011 BMC Cancer pmid:21649908
Gonzalez LO et al. Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors. 2008 BMC Cancer pmid:18507821
Kumar MJ et al. A mouse model for luminal epithelial like ER positive subtype of human breast cancer. 2007 BMC Cancer pmid:17880731
Seigne C et al. Characterisation of prostate cancer lesions in heterozygous Men1 mutant mice. 2010 BMC Cancer pmid:20663219
Xiaorong L et al. Underexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma. 2008 BMC Cancer pmid:18651974
Zavagno G et al. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. 2005 BMC Cancer pmid:15762990
Romanucci M et al. Heat shock protein expression in canine malignant mammary tumours. 2006 BMC Cancer pmid:16803633
Bacman D et al. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. 2007 BMC Cancer pmid:17692120
Toledo MT et al. Cancer during pregnancy alters the activity of rat placenta and enhances the expression of cleaved PARP, cytochrome-c and caspase 3. 2006 BMC Cancer pmid:16800886
Mesquita B et al. No significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatin. 2005 BMC Cancer pmid:16095531
Wang J et al. Case report: PET/CT, a cautionary tale. 2007 BMC Cancer pmid:17683560
Wu QW et al. Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer. 2012 BMC Cancer pmid:22284579
Macartney-Coxson DP et al. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. 2008 BMC Cancer pmid:18590575